Despite advances in modern medicine in recent decades, millions of people diagnosed with retinal dystrophy suffer severe visual impairment or even blindness.

To avoid animal testing, the reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) and the advancement of 3D retinal organoid technology offer a valuable opportunity to study, understand and even treat retinal diseases. In addition, materials for retinal prostheses based on organic semiconductor technology can be tested with the aim of restoring the limited functionality of retinal cells.

Our research focuses on two main goals: the establishment of a new retinal organoid model to explore therapeutic approaches while avoiding animal testing and the development of novel organic retinal prostheses.